drugset / Trial / NCT00947557

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

NCT00947557

Phase 3 Terminated 677 enrolled Forest Laboratories Phenomix · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the safety and efficacy of dutogliptin in patients with type 2 diabetes mellitus (T2DM) who are receiving background therapy of glimepiride with or without metformin.

Timeline

Start
2009-07
Primary completion
2010-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dutogliptin Small molecule Oral